ADAMTS8在无免疫检查点抑制剂/EGFR突变的肺癌患者中的治疗潜力

{"title":"ADAMTS8在无免疫检查点抑制剂/EGFR突变的肺癌患者中的治疗潜力","authors":"Y. Tsai, Y. Huang, C. Chang, L. Liu, K. Wu","doi":"10.1183/13993003.congress-2022.3639","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":229516,"journal":{"name":"11.01 - Lung cancer","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The therapeutic potential of ADAMTS8 in lung cancer patients without Immune checkpoint inhibitors/EGFR mutation\",\"authors\":\"Y. Tsai, Y. Huang, C. Chang, L. Liu, K. Wu\",\"doi\":\"10.1183/13993003.congress-2022.3639\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":229516,\"journal\":{\"name\":\"11.01 - Lung cancer\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"11.01 - Lung cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2022.3639\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"11.01 - Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2022.3639","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}